US HB2855 | 2021-2022 | 117th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on April 26 2021 - 25% progression, died in committee
Action: 2021-04-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Star Rating for Biosimilars Act

Sponsors


History

DateChamberAction
2021-04-27HouseReferred to the Subcommittee on Health.
2021-04-26HouseReferred to the Subcommittee on Social Security.
2021-04-26HouseReferred to the Subcommittee on Health.
2021-04-26HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-04-26HouseIntroduced in House

Same As/Similar To

HB5260 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
HB5237 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Subjects


US Congress State Sources


Bill Comments

feedback